Getting to an HIV cure: Investing now to avoid paying forever
This article was originally published in Scrip
While the astounding progress in HIV inhibition through antiretroviral therapy has been proclaimed one of the great successes in modern-day medicine, the chorus grew even louder at the third day of the AIDS 2012 conference in Washington for efforts to find a cure – with the single person whose infection is believed to have been eradicated declaring he is dedicating "my life, my body and my story" to that effort by establishing a new foundation.
You may also be interested in...
With new funding in hand, Moderna and its infectious disease venture Valera are going full-speed ahead with a Zika vaccine, taking an mRNA approach, which they said could be a more rapid strategy to try to stop the disease.
Allergan CEO Brent Saunders vows not to engage in price gouging and says his firm will limit cost increases to single-digit percentages, occurring only once per year. But it's unclear whether Saunders will stand as a lone wolf in the industry or if others will make similar pledges.
Hillary Clinton's plan to rein in high prices of older medicines, which includes creating a federal panel that has authority to impose fines, may grab headlines, but some analysts think it's unlikely to get very far in a divided Washington.